Induced pluripotent stem cells as cardiac arrhythmic in vitro models and the impact for drug discovery

By Šarić Tomo   Halbach Marcel   Khalil Markus   Er Fikret  

Expert Opinion on Drug Discovery, Vol. 9, Iss. 1, 2014-01 ,pp. : 55-76

Informa Healthcare

Access to resources Recommend Favorite

Cell based in vitro and ex vivo models in metabolic disease drug discovery: nice to have or critical path?

By Hallén Stefan   Clapham John C  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 4, 2009-04 ,pp. : 417-428

Informa Healthcare

Access to resources Recommend Favorite

New in silico and conventional in vitro approaches to advance HIV drug discovery and design

By Maga Giovanni   Veljkovic Nevena   Crespan Emmanuele   Spadari Silvio   Prljic Jelena   Perovic Vladimir   Glisic Sanja   Veljkovic Veljko  

Expert Opinion on Drug Discovery, Vol. 8, Iss. 1, 2013-01 ,pp. : 83-92

Informa Healthcare

Access to resources Recommend Favorite

In vitro and in vivo models of drug ototoxicity: studying the mechanisms of a clinical problem

By Yorgason Joshua G   Luxford William   Kalinec Federico  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 12, 2011-12 ,pp. : 1521-1534

Informa Healthcare

Access to resources Recommend Favorite

In vitro characterization of the human biotransformation pathways of aplidine, a novel marine anti-cancer drug

By Brandon Esther   Sparidans Rolf   Ooijen Ronald   Meijerman Irma   Lazaro Luis   Manzanares Ignacio   Beijnen Jos   Schellens Jan  

Investigational New Drugs, Vol. 25, Iss. 1, 2007-02 ,pp. : 9-19

Springer Publishing Company

Access to resources Recommend Favorite